Brightstar Associates LLC

Explore the detailed record of transactions filed by Brightstar Associates LLC. Director active across 1 company, notably Deciphera Pharmaceuticals, Inc.. Aggregated, 1 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €14.1m. History available since 29 April 2022. The latest transaction was disclosed on 29 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.